Associate Professor, Medicine, Brown University Program in Medicine
Cardiology
Dr. Barry L. Sharaf, MD
|
|
Give Review
Barry Sharaf works in the field of Cardiology. He went to medical school at Boston University School of Medicine. Boston University School of Medicine has a rank of 30 in research and a 52 in primary care He received 1 awards: "Fellow (FACC)". Doctor Barry L. Sharaf, MD is a published physician as well. He has 87 publications published. The latest was: Novel perfusion sleeve for use during balloon angioplasty: initial clinical experience. He is registered with Medicare and accepts Medicare payments.
Publications
- Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: An ancillary study of the National Heart, Lung, and Bloo...
- Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
- Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: Findings from the National Heart, Lung, and Blo...
- Increased wave reflection and ejection duration in women with chest pain and nonobstructive Coronary artery disease: ancillary study from the Women's Ischemia Syndrome...
- Sex differences in door to electrocardiogram and balloon times in patients with ST segment elevation Myocardial infarction.
- Left main pseudoAneurysm after postpartum coronary dissection.
- An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung a...
- Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive Coronary disease: results from the NHLBI-spon...
- Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Insti...
- Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-spons...
- Phytoestrogens and lipoproteins in women.
- Impaired Coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study.
- Electrocardiographic predictors of cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)...
- Inflammation, endothelial cell activation, and Coronary microvascular dysfunction in women with chest pain and no obstructive Coronary artery disease.
- Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.
- Relationship of physical fitness vs body mass index with Coronary artery disease and cardiovascular events in women.
- Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of Coronary disease: the NHLBI-sponsored Women's Ischemia Syndrome Evalua...
- Mild renal insufficiency is associated with angiographic Coronary artery disease in women.
- Large brachial artery diameter is associated with angiographic Coronary artery disease in women.
- Total estrogen time and obstructive Coronary disease in women: insights from the NHLBI-sponsored Women''s Ischemia Syndrome Evaluation (WISE).
- Association of anti-oxidized LDL and candidate genes with severity of Coronary stenosis in the Women''s Ischemia Syndrome Evaluation study.
- Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women''s Ischemia Syndro...
- Persistent chest pain predicts cardiovascular events in women without obstructive Coronary artery disease: results from the NIH-NHLBI-sponsored Women''s Ischaemia Synd...
- Migraines, angiographic Coronary artery disease and cardiovascular outcomes in women.
- The economic burden of angina in women with suspected ischemic Heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute...
- Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry).
- Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or Coronary artery disease in women evaluated for suspected ischemia: res...
- Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women''s Ischemia Syndrome Evaluation.
- Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected Myocardial ischemia. Results from the National In...
- Hypertension, menopause, and Coronary artery disease risk in the Women''s Ischemia Syndrome Evaluation (WISE) Study.
- Exercise treadmill testing using a modified exercise protocol in women with suspected myocardial ischemia: findings from the National Heart, Lung and Blood Institute-s...
- Insights from the NHLBI-Sponsored Women''s Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard t...
- Insights from the NHLBI-Sponsored Women''s Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluat...
- Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, ...
- Symptoms, Myocardial ischaemia and quality of life in women: results from the NHLBI-sponsored WISE Study.
- Metabolic syndrome modifies the cardiovascular risk associated with angiographic Coronary artery disease in women: a report from the Women''s Ischemia Syndrome Evaluat...
- Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women''s...
- Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored ...
- Electrocardiogram abnormalities predict angiographic Coronary artery disease in women with chest pain: results from the NHLBI WISE Study.
- Hypoestrogenemia of hypothalamic origin and Coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study.
- APOE polymorphism and angiographic Coronary artery disease severity in the Women''s Ischemia Syndrome Evaluation (WISE) study.
- The impact of myocardial flow reserve on the detection of Coronary artery disease by perfusion imaging methods: an NHLBI WISE study.
- B vitamins and restenosis after Coronary angioplasty.
- Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of Coronary artery disease.
- Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women''s Ischemi...
- Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Bl...
- Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women''s...
- Depression is associated with cardiac symptoms, mortality risk, and hospitalization among women with suspected Coronary disease: the NHLBI-sponsored WISE study.
- Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected Myocardial ischemia: The NHLBI-sponsored WISE study.
- A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive Coronary artery disease: results from the ...
- Preconditioning myocardium with demand ischemia in the presence of a critical Coronary artery stenosis.
- Safety and efficacy of a new regimen of intravenous recombinant tissue-type plasminogen activator potentially suitable for either prehospital or in-hospital administra...
- Results of percutaneous transluminal coronary angioplasty in unstable Angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB Trial.
- A detailed angiographic analysis of patients with ambulatory electrocardiographic ischemia: results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) study angiograp...
- Relation between ambulatory electrocardiographic monitoring and myocardial perfusion imaging to detect Coronary artery disease and myocardial ischemia: an ACIP ancilla...
- Clinical and arteriographic characterization of patients with unstable Angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial).
- Clinical and detailed angiographic findings in patients with ambulatory electrocardiographic ischemia without critical Coronary narrowing: results from the Asymptomati...
- Novel perfusion sleeve for use during balloon angioplasty: initial clinical experience.
- The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report.
- Dobutamine stress echocardiography in women with chest pain. Pilot phase data from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (W...
- Is a strategy of intended incomplete percutaneous transluminal Coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronar...
- Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel Disease: the Bypass Angioplasty Revascularization Investigation (BARI).
- IntraCoronary radiation : it keeps on glowing.
- Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal Coronary angiograms.
- Accuracy of dipyridamole SPECT imaging in identifying individual Coronary stenoses and multivessel disease in women versus men.
- In vivo uptake of radiolabeled antibody to proliferating smooth muscle cells in a swine model of Coronary stent restenosis.
- Physical activity and functional capacity measurement in women: a report from the NHLBI-sponsored WISE study.
- Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS).
- Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women''s Ischemia Syndrome Evaluation [WISE] Stud...
- Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of Coronary artery disease: results from the NHLBI WISE study.
- Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Relationship between exercise-induced and ambulatory ischemia in patients with stable Coronary disease.
- Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot st...
- Details of Coronary stenosis morphology influence its hemodynamic severity and distal flow reserve.
- Metabolic response to prolonged reduction of myocardial blood flow distal to a severe Coronary artery stenosis.
- Late (five to eight years) clinical and angiographic assessment of patients undergoing successful percutaneous transluminal Coronary angioplasty.
- Tissue acidosis: role in sustained arteriolar dilatation distal to a Coronary stenosis.
- Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
- Prognostic significance of Myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac...
- Factors influencing clinical outcomes after revascularization in the asymptomatic cardiac ischemia pilot (ACIP). ACIP Study Group.
- Coronary flow velocity response to adenosine characterizes Coronary microvascular function in women with chest pain and no obstructive Coronary disease. Results from t...
- Asymptomatic Cardiac Ischemia Pilot (ACIP) study: effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent Angina and ischemia. The ACIP i...
- Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABG.
- Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial.
- Origin of anterior interventricular vein blood in domestic swine.
- History of anxiety disorders is associated with a decreased likelihood of angiographic Coronary artery disease in women with chest pain: the WISE study.
- TIMI Frame Count and Adverse Events in Women with No Obstructive Coronary Disease: A Pilot Study from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Schools
Boston University School Of Medicine
Boston City Hospital
Rhode Island Hospital Lifespan
Rhode Island Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Fellow (FACC)
Education
-
Brown University -
Boston University Medical Center -
Boston University School of Medicine
Hospital
-
Rhode Island Hospital
Drug Facts
| NPI NUMBER | 1255352738 | |
| NPPES Provider LastName | SHARAF | |
| NPPES Provider FirstName | BARRY | |
| NPPES Provider ZIPCode | 029053236 | |
| NPPES Provider State | RI | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 1564.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1255352738 |
| Last Name Of The Provider | SHARAF |
| First Name Of The Provider | BARRY |
| View All |
Similar Doctors
|
|
Dr. Athena Poppas, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James F. Robertson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fredric V. Christian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas M. Drew, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip Stockwell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shafiq T. Mamdani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antony F. Chu, MD |
|
|
Dr. Michael F. Gilson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Levine, MD |